Marc Ferrante

66PUBLICATIONS
156CO-AUTHORS
Predictive and prognostic markersInformation systems development methodologies and practiceInnate immunityMolecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (66)

|Oct 26, 2026
Baseline Clearance and Early Troughs Identify Candidates for Early Therapeutic Drug Monitoring During Infliximab Induction in Inflammatory Bowel Disease.

|Oct 22, 2026
Shared decision making in inflammatory bowel disease: a qualitative study with patients, gastroenterologists, and nurses.

|Sep 25, 2026
Distinct intestinal eosinophil subsets in ulcerative colitis and their modulation by advanced inflammatory bowel disease therapies.

|Sep 11, 2026
Bridging preclinical and clinical efficacy of SIK2/SIK3 inhibition in inflammatory bowel disease through integrated murine, patient-derived models, and phase 2a trial-based analyses.

|Jul 23, 2026
Patient Preferences for Inflammatory Bowel Disease Treatment: Results from a Global Survey Conducted in Partnership with the European Federation of Crohn's & Ulcerative Colitis Associations.

|Apr 08, 2026
Why the Assay Matters in Model-Informed Precision Dosing: An Example of Ustekinumab in Crohn's Disease.

Wei Zhang, Zhigang Wang, Thierry Dervieux

Pageof 11

Frequent Collaborators

29 joint publications

Bram Verstockt

26 joint publications

Séverine Vermeire

9 joint publications

João Sabino

7 joint publications

Erwin Dreesen